跳至主要内容
临床试验/CTRI/2020/04/024422
CTRI/2020/04/024422尚未招募4 期

comparative effectiveness of cabergoline and medroxyprogesterone acetate in the treatment of adenomyosis: a randomised,open-label, parellal arm, controlled clinical trial

SRM College of Pharmacy0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1)age between 18-50 with complaints of chronic pelvic pain
  • 2)USG suggestive of Adenomyosis
  • 3)consenting to participate in the study
  • 4) use of barrier contraception or sexual abstinence during study period.

排除标准

  • 1) Women attempting pregnancy or currently pregnant
  • 2) less than six months postpartum
  • 3)lactating mothers

研究者

发起方
SRM College of Pharmacy

相似试验